Introduction

With the application of new technologies such as optogenetics [1], neural mechanisms underlying brain functions, particularly behavioral brain mechanisms, have been extensively investigated [2,3,4,5]. Decoding neural circuits has become a vital goal in the study of behavioral brain mechanisms. Because of the complexity of neural circuits, it is exceptionally challenging to analyze the entire circuitry involved in specific behaviors. Practically, before completely dissecting the complicated neural circuitry, it is necessary to first identify the upstream and downstream neurons that have direct synaptic (monosynaptic) connections with the neurons of interest [6,7,8]. The most commonly used method for morphologically identifying monosynaptic connections is the recently developed trans-synaptic viral tracing technique, which includes retrograde [9,10,11,12,13,14] tracing systems to identify upstream neurons and anterograde [15,16,17,18] tracing systems to identify downstream neurons. With the use of optogenetics to specifically stimulate the terminals of neurons of interest projecting to specific target areas and simultaneously recording postsynaptic potentials in the target area neurons, combined with pharmacological analysis, it is feasible to functionally identify whether there are direct monosynaptic connections between two types of neurons or whether there are polysynaptic connections mediated by other neurons [4, 19,20,21]. Together with the pharmacological approach, it is also feasible to determine whether the connection is excitatory glutamatergic or inhibitory GABAergic [2, 5, 22, 23].

In this paper, on the basis of the literature reported and the experience accumulated in our laboratory, we provide a comprehensive description of the morphological identification of monosynaptic connections using viral tracing and the functional identification of monosynaptic connections using optogenetics combined with electrophysiological recordings and pharmacological methods (Fig. 1). We also highlight important technical considerations and potential issues in the experimental procedures for the convenience and feasibility of the techniques.

Fig. 1
figure 1

Schematic summary for identification of the monosynaptic innervation. The morphological identification of monosynaptic connections is achieved by employing viral tracing. The functional identification of monosynaptic connections involves the integration of optogenetics with electrophysiological recordings and pharmacological methods.

Full size image

Viral Tracing Strategy

Anterograde

Herpes Simplex Virus

Herpes simplex virus (HSV) is a double-stranded DNA virus with an anterograde trans-synaptic transmission function. Zeng et al. [15] successfully engineered a modified form of the H129 strain of HSV1, known as H129-ΔTK-tdT, through the deletion of the thymidine kinase (TK) gene from its genetic makeup. This modification enabled the virus to selectively cross a single synapse. However, the use of this HSV variant still necessitates the presence of a helper virus that expresses TK. With the use of AAV-TK-GFP, anterograde tracing has been achieved in wild-type mice, whereas AAV-DIO-TK-GFP facilitates the specific labeling of downstream neurons in mice expressing Cre recombinase in specific types of neurons. Recently, Yang et al. [16] created H129-dTK-T2, an updated version of H129-dTK-tdT, which has improved labeling intensity. However, the pronounced neurotoxicity of HSV poses considerable limitations on its utility for the long-term and precise mapping of neural circuits [24,25,26].

Recombinant Adeno-associated Virus

Recombinant adeno-associated virus (rAAV) was derived as a gene transfer vector from the wild-type AAV, a member of the Parvoviridae family and the Dependovirus genus. A diverse range of 13 serotypes [24] (AAV1–13) and > 100 variants have been identified across various host species. AAV1, AAV2, AAV5, AAV8, and AAV9 are among the commonly used serotypes in neural circuits [25]. Among them, AAV1 and AAV9 have been reported to have the ability to label neurons anterogradely across synapses [17]. It should be stated that in comparison with HSV, AAV1 may have a lower probability of retrogradely labeling neurons. However, rAAV is capable of achieving the long-term and stable expression of foreign genes in vivo primarily because of its low immunogenicity, diverse serotypes, and broad host cell tropism.

Synaptophysin is a membrane protein predominantly located within the synaptic vesicles of neurons and serves as a reliable marker for synaptic terminals [18, 27]. It is commonly used in immunohistochemical studies to visualize [18, 28, 29] and quantify [4] synaptic terminals in brain tissue sections, facilitating investigations into synaptic connectivity, development, and activity. It can be used to differentiate transit fibers from actual synaptic terminals. Synaptophysin is commonly delivered using AAV vectors, which can be engineered with various promoters to achieve expression in wild-type mice or in a Cre-dependent manner.

Retrograde

Rabies Virus

The wild-type rabies virus (RV) is an RNA virus that spreads well between synaptically connected neurons in a retrograde manner. However, its broad infectivity prevents its direct use for monosynaptic tracking [11, 12]. To selectively label neurons that possess monosynaptic connections to specific cell types, researchers developed a modified RV system that relies on the synergistic action of Cre recombinase and helper virus [9, 11, 12, 30,31,32,33,34]. Glycoprotein promotes the fusion of virus and host cell membranes and provides internalized virus particles with intracellular transport characteristics, infecting presynaptic terminals to bring the retrograde trans-synaptic transmission of the RV into effect. RV-ΔG pseudotyped with EnvA, the avian sarcoma, and leukosis virus A protein, cannot infect mammalian neurons. It can only infect cells that are specially engineered to express the avian cell-surface molecule tumor virus A (TVA), the receptor of EnvA. This receptor-ligand pair (TVA-EnvA) allows specific infection of target neurons. RV-ΔG is replication-deficient, so it cannot spread beyond the initially infected neurons unless the glycoprotein is supplied. With the adeno-associated helper virus that expresses TVA and RVG, the virus can produce infectious progeny, which spread from these neurons to the presynaptic neurons directly connected to them [24, 30, 35, 36].

Canine Adenovirus Type 2

Canine adenovirus type 2 (CAV-2) exhibits high efficiency in transducing axon terminals and undergoes retrograde transport to reach the cell bodies of upstream neurons [37]. CAV-2 stands out because it relies on a single, highly conserved cell adhesion molecule known as the Coxsackie virus and adenovirus receptor [38]. CAV-2 is commonly engineered to express Cre recombinase, which is subsequently injected into a specific region. Following this, a Cre-dependent AAV is administered into the targeted upstream nucleus. CAV-cre is transported retrogradely from the distal axon terminals to the cell body, facilitating the expression of Cre recombinase in the nucleus. Consequently, the target gene is selectively activated in a subset of neurons that project from the source to the target area [25, 39].

rAAV2-retro

rAAV2-retro is a genetically engineered version of AAV2 that has undergone a selection process driven by evolution to enhance its effectiveness in retrograde axonal transport. It is efficiently captured by axon terminals and undergoes retrograde transport to reach the cell bodies in remote brain regions, where transgene expression can be observed [40]. The rAAV2-retro system can be used independently or in combination with Cre recombinase driver lines to establish sustained and robust transgene expression, facilitating the efficient exploration of neural circuit function [14]. However, rAAV2-retro does not appear to work well in the viral tracing involved in GABAergic neurons in our practical applications.

During the last decade, immense changes have transpired in neural circuit research owing to the rapid development of viral tools. Here, we summarize viruses commonly used for neural circuits (Table 1).

Table 1 Popular viral tracing strategies for neural circuit.
Full size table

Electrophysiology Combined with Optogenetics

The patch-clamp technique is currently the most common technology used to study the action potential (AP) and neural activity [41,42,43]. Optogenetics can be used to visualize neurons of the central nervous system and achieve remote control of animal behaviors through the photostimulation of particular types of neurons [1, 44, 45]. Boyden et al. first established a method combining in vivo electrophysiology and optogenetics to precisely control the excitability and excitatory or inhibitory synapses of specific neurons [19].

The adeno-associated virus expressing Channelrhodopsin-2 (ChR2) is first injected into the upstream nucleus, then the downstream terminals are photostimulated, and the postsynaptic potentials produced on the cells surrounded by the terminals are recorded using the whole-cell patch-clamp technique [1]. The application of tetrodotoxin (TTX; 1 μM) blocks voltage-gated Na+ channels, the generation or conduction of AP is prevented, and the AP-dependent terminal depolarization and synaptic transmission are eliminated [46] (Fig. 2). Thus, light stimulation fails to induce APs and postsynaptic potentials in both monosynaptic and polysynaptic connected neurons in the presence of TTX (Fig. 2). The application of 4-aminopyridine (4-AP; 100 μM) not only blocks K+ channels that induce membrane depolarization and increase the membrane resistance but also directly facilitates Ca2+ channels [47], thus amplifying the ChR2-mediated depolarization of presynaptic terminals and presynaptic Ca2+ channel activation. The postsynaptic responses (excitatory or inhibitory postsynaptic potential) in monosynaptically innervated neurons are thus recorded again even if in the presence of TTX (Fig. 2). Simply put, in the presence of 4-AP, TTX can only block AP-induced terminal depolarization and synaptic transmission in polysynaptically connected neurons but not the light-induced depolarization of ChR2-expressing terminals and synaptic transmission in monosynaptically connected neurons (Fig. 2). In addition, the application of specific receptor antagonists helps to verify the type of the transmitter involved in the monosynaptic connection [41, 42]. The application of a glutamate receptor antagonist effectively blocks the excitatory postsynaptic current, providing evidence that the monosynaptic connection is mediated by glutamatergic transmission. Glutamate antagonists are primarily classified into two categories: non-N-methyl-d-aspartate receptor antagonists (including 6-nitro-7-sulfamoylbenzo(f)-quinoxaline-2,3-dione, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 6,7-dinitroquinoxaline-2,3-dione), N-methyl-d-aspartate receptor antagonists (such as d-2-amino-5-phosphonovaleric acid and dizocilpine). By applying a GABA receptor antagonist, the inhibitory postsynaptic current is effectively blocked, presenting compelling evidence that the monosynaptic connection operates through GABAergic transmission. The GABAA receptors serve as the binding sites for commonly applied GABA receptor antagonists in electrophysiology, including bicuculline, picrotoxin, and GABAzine (4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol) [2,3,4, 29, 48,49,50].

Fig. 2
figure 2

Functional identification of monosynaptic connections by optogenetics combined with electrophysiology and pharmacology. Optogenetic stimulation (blue light, 473 nm) in the downstream target area of axon terminals of neurons (green) expressing ChR2 evokes the “all-or-none” AP (1), which induces significant depolarization (2, black trace), activating voltage-gated Ca2+ channels in the terminals and triggering synaptic vesicle release, resulting in a postsynaptic potential in the monosynaptic connected neurons (3, black trace). This AP can also propagate retrogradely (backpropagation) along the axon toward the cell body (4) and spread through axon collaterals, triggering excitation in the intercalated neurons (black), which induces AP-driven terminal depolarization (5, black trace) and postsynaptic potential (6, black trace) in the polysynaptically connected neurons (yellow). Application of the Na+ channel blocker TTX can block the generation and propagation of APs induced by optogenetic stimulation, thereby blocking AP-driven terminal depolarization and the postsynaptic potentials in both monosynaptically (2 and 3, red traces) and polysynaptically connected neurons (5 and 6, red traces). Although optogenetic stimulation can induce small depolarization in ChR2-expressing neural terminals (2, red trace), this depolarization is insufficient to induce voltage-gated Ca2+ channel activation and synaptic vesicle release. Application of 4-AP increases membrane depolarization, membrane resistance, and Ca2+ channel activation, which amplifies the optogenetic-induced Ca2+ influx in ChR2-expressing neural terminals (2, blue trace) and triggers synaptic vesicle release, thereby inducing postsynaptic potentials in monosynaptically connected neurons (3, blue trace). However, in the polysynaptically connected neurons, postsynaptic potentials cannot be recorded (6, blue trace) because of a lack of direct light-induced neural terminal depolarization. Pharmacological approaches can further identify the neurotransmitter type involved in synaptic transmission, which in the brain is primarily excitatory glutamatergic synapses and inhibitory GABAergic synapses (3, yellow trace).

Full size image

The light-induced responses of monosynaptically and polysynaptically innervated neurons under different treatments are also listed in Table 2.

Table 2 Light-induced responses in mono- and polysynaptic innervated neurons under various treatments.
Full size table

Procedures

First Strategy: Monosynaptic Retrograde Viral Tracing in Adult Mice (Fig. 3 )

Fig. 3
figure 3

Equipment required for stereotaxic injections and microscopic imaging in mouse brain. A Equipment setup for the virus injection. B Fix the mouse on the stereo apparatus, expose the skull by incising the scalp, and apply erythromycin ointment on both eyes. C The parameter setup of virus injection on the syringe pump (KD Scientific). D Inject the virus using a glass pipette (Sutter Instrument). E The coordinates of the LPB. F and G Slice the brain using CryoStar NX50 OP cryostat (Thermo). H Fast large-scale imaging system for examining the distribution pattern of virus-infected neurons across the whole brain using the virtual digital slide slice scanning system VS120 (Olympus) (1, mercury lamp; 2, microscope controller; 3, electric stage controller; 4, 16-bit sCMOS camera; and 5, computer). I High-magnification imaging system for the comprehensive examination of the distribution of virus-infected neurons and their axon terminals in the local brain area using the laser scanning confocal microscope FV-1200 (Olympus) (1, microscope power supply system; 2, mercury lamp; 3, main controller; and 4, microscope touch operating system). J FV10-ASW application software.

Full size image

Step 1: Viral Stereotaxic Intracerebral Injections

! CAUTION Make sure that the biosafety level of the laboratory when applying tracing virus is at least ABSL-2 (P2).

  • X-Cre mice aged 8–10 weeks are prepared for surgery.

  • Each mouse is anesthetized and positioned in the stereotactic frame.

  • All stereotaxic surgeries are performed under pentobarbital sodium (0.1 g/kg i.p.) anesthesia (Fig. 3A).

  • Each mouse’s head is fixed on a stereotaxic apparatus (RWD, Shenzhen, China) (Fig. 3D).

  • Erythromycin ointment is applied to maintain eye lubrication (Fig. 3B).

  • The mouse’s head is aligned horizontally, ensuring that the height difference between the front and rear fontanels is minimal, ideally < 0.05 mm.

  • The location of the lateral parabrachial nucleus (LPB, bregma, 5.10 mm; lateral, ±1.33 mm; ventral, 3.40 mm) is verified using the stereotaxic apparatus (RWD) under the binocular stereotaxic microscope (Olympus, Tokyo, Japan).

  • A manual drill (Saeshin Precision, Daegu, Korea) with a round tip drill bit (Hager & Meisinger GmbH, Centennial, CO, USA) is used to open the skull, exposing the brain surface above the target area.

  • A saline-soaked cotton pad is used to wipe the skull, maintaining its cleanliness and moisture.

  • For monosynaptic retrograde tracing, 60–80 nL of a mixture (1:1) of AAV2/9-rAAV-EF1α-DIO-oRVG-WPRE-hGH pA (5.40 × 1012 genomic copies per mL, BrainVTA, Wuhan, China) and AAV2/9-rAAV-EF1α-DIO-H2B-EGFP-T2A-TVA-WPRE-hGH pA (5.24 × 1012 genomic copies per mL, BrainVTA) is unilaterally injected into the LPB at 40 nL/min using a single syringe infuse/withdraw system (KD Scientific, Holliston, MA, USA) connected to a glass pipette (tip diameter 10–30 μm, Sutter Instrument, Novato, CA, USA) (Fig. 3 C–E).

▲CRITICAL STEP The pipette is withdrawn 10–15 min after the end of the infusion. The incision is closed with a suture and a tissue adhesive (Vetbond; 3M, St Paul, MN, USA).

! CAUTION Make sure to sterilize the scalp with iodophor to avoid bacterial infection.

  • Three weeks later, 80–100 nL of EnvA-pseudotyped, glycoprotein (G)-deleted and DsRed-expressing RV (RV-EnVA-ΔG-DsRed) (5.0 × 108 genomic copies per mL, BrainVTA) is injected into the same site of LPB.

▲CRITICAL STEP The injection needle is withdrawn 10–15 min after the end of the infusion and the incision is closed with a suture and a tissue adhesive (Vetbond; 3M).


Step 2: Perfused Fixation

  • One week after injection of RV-EnVA-ΔG-DsRed, mice were deeply anesthetized and transcardially perfused with 0.1 mol/L of PBS and 4% paraformaldehyde in PBS.

  • Their brains are then removed and fixed in 4% paraformaldehyde buffer at 4°C overnight. After fixation, the brains are cryoprotected in 30% sucrose (wt/vol) at 4°C for at least 48 hours to ensure complete dehydration.

▲CRITICAL STEP When the brain has completely sunk to the bottom of the 30% sucrose solution, it can be determined that the brain is adequately dehydrated and ready for sectioning. Otherwise, there is a risk of damaging the brain tissue during the frozen section procedure.


Step 3: Serial Frozen Sections

  • Brains frozen in optimal cutting temperature compound (Sakura, Torrance, CA, USA) were sectioned at 40 μm in the coronal plane using the CryoStar NX50 OP cryostat (Thermo, Waltham, MA, USA) (Fig. 3F, G).


Step 4: Immunohistochemistry

  • The brain slices are rinsed three times with 0.1 mol/L of PBS for 5 min each.

  • The samples are incubated in DAPI (Beyotime, Shanghai, China) for 2 min.

  • The samples are sealed with a mounting medium (90% glycerol in 0.1 mol/L PBS).

! CAUTION Do not shake the mounting medium, and make sure there are no bubbles within the mounting medium. If there are bubbles in it, place the medium in the fridge and let it sit for 1 h before use.


Step 5: Microscopic Imaging

  • Brain sections are imaged using a virtual digital slide slice scanning system VS120 (Olympus) (Fig. 3H) for whole-brain screening of the regions that are labeled with rabies. Then, each rabies-labeled nucleus was imaged at high resolution using a laser scanning confocal microscope FV-1200 (Olympus) for individual cell morphology analysis and quantitative statistics (Fig. 3I, J).

Second Strategy: A Combination of Electrophysiology and Optogenetics to Identify Functional Monosynaptic Connections in Acute Brain Slices (Fig. 4 )

Fig. 4
figure 4

Schematic of functional identification of monosynaptic connection by electrophysiology combined with optogenetics and pharmacological approaches using the brain slice preparation. The AAV-CaMKIIα-mCherry and AAV-DIO-ChR2-EGFP viruses were injected into the LPB of X-Cre mice for 3 weeks, each mouse was anesthetized with isoflurane, and their brains were dissected rapidly, and immersed in ice-cold oxygenated (95% O2/5% CO2) cutting solution. Coronal slices (300 μm, magnified view of the first dashed area LPB) were cut on a vibratome and then allowed to recover in the recording solution. Neurons, axons, and synaptic terminals expressing ChR2 are activated by 10 ms flashes of blue light (473 nm, 1 Hz) from a single-wavelength laser system. To confirm that postsynaptic currents are monosynaptic, EPSCs (recorded at −50 mV membrane potential) or IPSCs (recorded at 0 mV membrane potential) were recorded in ACSF containing TTX (1 μmol/L), followed by a combination of TTX and 4-AP (100 μmol/L). The second dashed area is the magnified view of the electrophysiology process in the LPB from coronal slices. Refer also to Fig. 2.

Full size image

Step 1: Viral Stereotaxic Intracerebral Injections

! CAUTION Make sure that the biosafety level of the laboratory when applying tracing virus is at least ABSL-2 (P2).

  • X-Cre mice aged 8–10 weeks are prepared for surgery.

  • The mice are anesthetized and positioned in the stereotactic frame.

  • All stereotaxic surgeries are performed under pentobarbital sodium (0.1 g/kg i.p.) anesthesia (Fig. 3A).

  • The mice’s heads are fixed on a stereotaxic apparatus (RWD) (Fig. 3D).

  • Erythromycin ointment is applied to maintain eye lubrication (Fig. 3B).

  • The mouse’s head is aligned horizontally, ensuring that the height difference between the front and rear fontanels is minimal, ideally < 0.05 mm.

  • The location of the LPB is verified using the stereotaxic apparatus (RWD) under the binocular stereotaxic microscope (Olympus).

  • A manual drill (Saeshin Precision) with a round tip drill bit (Hager & Meisinger GmbH) is used to open the skull, exposing the brain surface above the target area.

  • A saline-soaked cotton pad is used to wipe the skull, maintaining its cleanliness and moisture.

  • 120 nL of a mixture (working titer at ~ 2–5 × 1012 genomic copies per mL) of pAAV2/9-CaMKIIα-mCherry (2.13 × 1012 genomic copies per mL original, SunBio, Shanghai, China) and AAV2/9-hEF1α-DIO-hChR2(H134R)-EYFP-WPRE-pA (1.72 × 1013 genomic copies per mL original, Taitool Bioscience, Shanghai, China) was unilaterally injected into the LPB at 40 nL/min using a single syringe infuse/withdraw system (KD Scientific) connected to a glass pipette (tip diameter 10–30 μm, Sutter Instrument) (Fig. 3C–E).

▲CRITICAL STEP The pipette is withdrawn 10–15 min after the end of the infusion. The incision is closed with a suture and a tissue adhesive (Vetbond; 3M).

! CAUTION Make sure to sterilize the scalp with iodophor to avoid bacterial infection.


Step 2: Sacrifice and Sampling

  • Two weeks after the virus injection, mice are deeply anesthetized with pentobarbital sodium (0.1 g/kg i.p.).

! CAUTION Follow appropriate guidelines and regulations for animal experiments.

  • Mice are intracardially perfused with ice-cold artificial cerebrospinal fluid (ACSF, cutting solution). Then the brain is rapidly dissected and immersed in ice-cold oxygenated (95% O2/5% CO2) cutting solution.

▲CRITICAL STEP This step must be executed swiftly to ensure the viability of the tissue, ideally in < 2 min.

! CAUTION Be careful when extracting brain tissue; do not compromise the organizational integrity.


Step 3: Brain Slices Preparation

  • The brain tissue is trimmed and affixed to the microtome base using super glue.

! CAUTION It is essential to avoid applying excessive mechanical force to the brain tissue as this could lead to damage.

  • Coronal slices of the LPB (300 μm) were cut on a vibrating blade microtome (Leica, Wetzlar, Germany).

▲CRITICAL STEP It is recommended to maintain a slicing speed of 0.08 mm/s, avoiding extremes of too fast or too slow, with an amplitude set of ~ 1.8 mm.

  • Slices are transferred to a small baker with an oxygenated recording solution and the slices are allowed to recover in the recording solution for at least 1 h at 32°C.

▲CRITICAL STEP Ensure there are no air bubbles while oxygenating the slices; the presence of bubbles can cause the slices to float, potentially leading to cell damage.

! CAUTION All solutions should be oxygenated with 95% O2/5% CO2 at 0–4°C (ice-liquid mixture).


Step 4: Recording

  • Slices are transferred to a recording chamber on an antivibration table (TMC, Peabody, MA, USA) and perfused with an oxygenated recording solution.

  • A constant flow of recording solution at a rate of 2–4 mL/min is maintained using a peristaltic pump (Longer Pump, Hebei, China), and the temperature of the recording solution is controlled at ~ 30°C using an automatic temperature controller (Warner, Holliston, MA, USA).

  • LPB neurons expressing mCherry also surrounded by ChR2-EGFP axon terminals are visualized under a microscope (a 40× water-immersion objective on an upright fluorescent microscope, Olympus) with a high-performance CCD Camera (COHU, Poway, CA, USA) and a black white monitor (Sunspo, Guangdong, China).

  • Borosilicate glass pipettes are prepared using a horizontal pipette puller (Sutter Instrument).

▲CRITICAL STEP Keep the resistance within 3–5 MΩ.

  • The pipette is filled with the corresponding internal solutions for light-evoked inhibitory postsynaptic currents (IPSCs) or light-evoked excitatory postsynaptic currents (EPSCs) (See the “Material, Reagents and Equipment” for details).

! CAUTION For IPSCs recording, 20 μmol/L CNQX and 50 μmol/L D-AP5 are added to the recording solution to block AMPA and NMDA receptors, respectively. For EPSCs recording, a total of 100 μmol/L picrotoxin is added to the recording solution to block inhibitory currents mediated by GABAA receptors.

  • The pipette is gently moved over the targeted cell by a Sutter MPC-200 micromanipulator (Sutter Instruments).

  • A small positive pressure (about 0.3 mL air) was applied to the pipette by a 1 mL syringe.

  • After obtaining a whole-cell recording, ChR2 is stimulated by flashing (5 ms) 473 nm light through the light path of the microscope using an ultrahigh-powered light-emitting diode (LED, Excelitas Technologies, Waltham, MA, USA) powered (5 mW/mm2) by a LED driver under computer control.

  • Light-evoked GABAA responses or AMPA responses are obtained every 10 s with one pulse of 473 nm light with neurons voltage clamped at 0 mV or −50 mV. Signals are amplified with Multiclamp 700A (Molecular Devices, filtered at 2 kHz, San Jose, CA, USA), digitized with Digidata 1440 A (Molecular Devices, 5 kHz), and recorded using pClamp 10.4 software (Molecular Devices) and the Mini Analysis program (Synaptosoft).

  • Identifying monosynaptic inputs:

TTX (1 μmol/L, Hello Bio, Meath, Ireland) is added to the ACSF using the micromanipulator (Sutter Instrument) and the signals are recorded.

! CAUTION TTX is a highly potent neurotoxin and should be handled with utmost care.

4-AP (100 μmol/L) is added to the ACSF and the signals are recorded.

! CAUTION 4-AP is a potent neurotoxin and should be handled with utmost care.

Results

Using the G-deleted RV-based tracing strategy, we injected helper viruses AAV2/9-EF1α-DIO-RVG and AAV2/9-EF1α-DIO-TVA-EGFP on day 1 and RV-EnVA-ΔG-DsRed on day 21 into the LPB of X-Cre mice. On day 28, we observed the localization of starter cells (indicated in yellow) in the LPB nucleus and retrogradely labeled neurons in multiple regions, which suggests that X+ LPB neurons directly receive monosynaptic inputs from the STLD, PSTH, PVN, CEA, ZI, DMPAG, VLPAG, LC, PCRtA, and NTS (Fig. 5).

Fig. 5
figure 5

Whole-brain mapping of monosynaptic inputs to X-type neurons in the LPB. A Schematic of AAV helper virus (DIO-TVA and DIO-RVG) and rabies virus (EnvA-RV-DsRed) injections into the LPB of X-Cre mice. B Representative images of monosynaptic rabies spread from X+ LPB neurons in X-Cre mice. Arrowheads indicate starter neurons infected by both TVA-EGFP (green) and rabies virus (red). Magnified views of the boxed areas. Scale bars, 200 μm, 100 μm, and 10 μm (magnified views). C Percentage of starter cells that co-express with total GFP labeled cells or total RV labeled cells in the LPB (n = 6 sections from 3 mice). D Representative images of retrogradely labeled neurons in the LPB of X-Cre mice, receiving direct monosynaptic inputs from the STLD, PSTH, PVN, CEA, ZI, DMPAG, VLPAG, LC, PCRtA, and NTS (areas shown by dashed lines). STLD, bed nucleus of the stria terminal, lateral division, dorsal part; PVN, paraventricular hypothalamic nucleus; CeA, central amygdaloid nucleus; ZI, zona incerta; PSTh, parasubthalamic nucleus; DMPAG, dorsomedial periaqueductal gray; VLPAG, ventrolateral periaqueductal gray; LC, locus coeruleus; PCRtA, parvicellular reticular nucleus, alpha part; and NTS, nucleus of the solitary tract. Scale bars, 200 μm and 10 μm (magnified views).

Full size image

Discussion

We outlined two distinct, streamlined, and readily reproducible protocols for monosynaptic neuronal tracing in adult mice. By harnessing the power of versatile recombinases, viral tools, and electrophysiology, researchers can selectively label subpopulations of specific neurons. These approaches significantly facilitate investigations into the interactions between different brain regions, encompassing a broad spectrum of trans-synaptic neural circuit tracing. These methods are designed to expedite the mastery of these experimental techniques for any researcher.

The implementation of a viral tracing strategy renders the validation of single-synapse tracing in terms of morphology attainable and robust. The adapted RV system enables the selective labeling of a single neuron type across species, facilitating the search for upstream nuclei with monosynaptic connections. The synergistic use of helper viruses and transgenic mice serves to effectively restrict G and TVA expression to specific cells in particular locations, minimizing G expression in other neurons and the potential for trans-synaptic viral spread. This comprehensive approach yields unparalleled insights into the neural circuit mechanisms governing behavioral encoding and the formation of functional brain maps. Nevertheless, the current viral strategy still has limitations in various aspects, including, but not limited to, their capacity to label only a portion of input cells, resulting in variable labeling efficiency of these cells. Despite the retrograde propagation of RV exclusively between connected central nervous system neurons, anterograde labeling may occur in peripheral sensory neurons. The adapted rabies virus retains a certain level of toxicity, and prolonged expression can lead to neuronal death. Nonetheless, another drawback lies in necessitating a second craniotomy, a procedure with slight risks that demands a high level of precision during surgery. The post-initial craniotomy suturing is especially crucial because suboptimal recovery and the development of skull lesions can compromise the accuracy of the subsequent craniotomy [12].

Moreover, patch-clamp techniques offer an additional electrophysiological dimension for confirming single-synapse tracing. Recent findings lend strong support to the idea that combining electrophysiology with optogenetics furnishes unequivocal proof of single-synapse tracing, now considered the gold standard for validating neuronal functional connectivity [19, 51]. Electrophysiological methods empower researchers to delve into neuronal connections and distributions in diverse animal models with enhanced temporal and spatial precision. Experimenters gain greater control over experimental parameters like voltage, current, and other stimulation modes, enabling long-term recordings of single cell membrane potentials. However, using electrophysiological techniques to confirm synaptic connections between neurons does come with some notable challenges. The execution of these experiments demands a high degree of specialized expertise, encompassing tasks like cell clamping, the amplifier, and fine-tuning the data acquisition system, as well as intricate data analysis. Novices might encounter a learning curve in this regard. At the same time, it is essential for the laboratory to be equipped with costly instruments and the necessary facilities. Furthermore, the patch-clamp technique must be performed after using viral tools to find potential upstream nuclei as a means to further verify synaptic connections.

Although both methods described above can be used to confirm monosynaptic connections, their prerequisites and underlying functions are different. Specifically, the modified rabies virus is employed to survey potential upstream nuclei throughout the entire brain during the initial stages of the experiment-a function absent in electrophysiological techniques. In contrast, patch-clamp technology enables a detailed analysis of monosynaptic connections by manipulating drug components in the recording system, a capability not achievable with the modified rabies virus.

Material, Reagents, and Equipment

Material

Source

Identifier

Viral Vectors

RV-EnVA-ΔG-DsRed

BrainVTA

cat. # R0002

AAV2/9-rAAV-EF1α-DIO-oRVG-WPRE-hGH pA

BrainVTA

cat. # PT-0023

AAV2/9-rAAV-EF1α-DIO-H2B-EGFP-T2A-TVA-WPRE-hGH pA

BrainVTA

cat. # PT-0021

AAV2/9-hEF1α-DIO-hChR2(H134R)-EYFP-WPRE-pA

Shanghai Taitool Bioscience

cat. # S0199-9

pAAV2/9-CaMKIIα-mCherry

SunBio

cat. # PMT191

Others

Tissue adhesive

3M

cat. # 1469SB

Optimal cutting temperature compound

Sakura

cat. # 4583

Borosilicate glass pipettes

Sutter Instrument

cat. # B120-69-15

Reagents

Source

Identifier

NaCl

Sigma-Aldrich, St Louis, MO, USA

cat. # S3014-1KG

KCl

Sigma-Aldrich

cat. # P5405-500G

MgSO4

Sigma-Aldrich

cat. # M1880-500G

NaHCO3

Sigma-Aldrich

cat. # S5761-1KG

KH2PO4

Sigma-Aldrich

cat. # P5655-1KG

CaCl2

Sigma-Aldrich

cat. # C3881-500G

MgCl2

Sigma-Aldrich

cat. # M0250-500G

d-glucose

Sigma-Aldrich

cat. # G7021-1KG

CsCl

Sigma-Aldrich

cat. # 289329-25G

EGTA

Sigma-Aldrich

cat. # E4378-100G

NMDG

Sigma-Aldrich

cat. # M2004-1KG

NaH2PO4

Sigma-Aldrich

cat. # 71505-1KG

HEPES

Sigma-Aldrich

cat. # H4034-1KG

Thiourea

Sigma-Aldrich

cat. # T8656-100G

l-Na-ascorbate

Sigma-Aldrich

cat. # V900326-500G

Na-pyruvate

Sigma-Aldrich

cat. # P2256

HCl

Sigma-Aldrich

cat. # H1758

Glucose

Sigma-Aldrich

cat. # G8270

QX-314

Sigma-Aldrich

cat. # 552233

ATP-Na

Sigma-Aldrich

cat. # A6419

GTP-Na

Sigma-Aldrich

cat. # 51120

4-aminopyridine (4-AP)

Sigma-Aldrich

cat. # 275875

Paraformaldehyde (PFA)

Sigma-Aldrich

cat. # 16005-1KG-R

NaH2PO4·2H2O

Sinopharm Chemical Reagent, Shanghai, China

cat. # 20040718

Na2HPO4·12H2O

Sinopharm Chemical Reagent

cat. # 10020318

Sucrose

Sinopharm Chemical Reagent

cat. # 10021418

DAPI

Beyotime

cat. # 1006

Tetrodotoxin (TTX)

Hello Bio

cat. # HB1034

Solutions

Preparation

Saline

This solution was prepared by dissolving 9 g of NaCl in distilled water for a total volume of 1 L

0.1 mol/L Phosphate buffered saline (PBS)#

This solution was prepared by dissolving 71.64 g of Na2HPO4·12H2O in distilled water for a total volume of 1 L as buffer A, dissolving 31.21 g of NaH2PO4·2H2O in distilled water for a total volume of 1 L as buffer B, mixing 81 mL of buffer A and 19 mL of buffer B, and adjusting osmolarity with NaCl

4% Paraformaldehyde (4% PFA)

This solution was prepared by dissolving 40 g of PFA in 0.1 M PBS for a total volume of 1 L

30% Sucrose (wt/vol)

This solution was prepared by dissolving 30 g of sucrose in 0.1 M PBS for a total volume of 1 L

Artificial cerebrospinal fluid (ACSF, cutting solution)*#

This solution contained (in mmol/L) 50 sucrose, 125 NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 0.1 CaCl2, 4.9 MgCl2, and 2.5 glucose and was bubbled with carbogen (95% O2/5% CO2) (pH 7.35; 270–285 mOsm)

Recording solution*#

This solution contained (in mM) 125 NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 11 glucose, 1.3 MgCl2 and 2.5 CaCl2 (pH 7.35; 270–285 mOsm)

Pipette internal solution (EPSC)*#

This solution contained (in mmol/L) 117 CsCH3SO3, 20 HEPES, 0.4 EGTA, 2.8 NaCl, 5 TEA, 4 MgATP, 0.3 NaGTP, 5 QX314 and 0.1 spermine at pH 7.35 (270–285 mOsm)

Pipette internal solution (IPSC)*#

This solution contained (in mmol/L) 130 CsCl, 1 EGTA, 10 HEPES, 2 MgATP, 0.2 NaGTP, pH 7.35 (270–285 mOsm)

*The osmotic pressure of these solutions was adjusted by a freezing point osmometer (Löser, Berlin, Germany).

#The pH of these solutions was adjusted by a pH meter (Mettler Toledo, Greifensee, Schweiz).

Equipment and Software

Source

Identifier

Equipment

Stereotaxic apparatus

RWD

68046

Binocular stereotaxic microscope

Olympus

SZ61

Single syringe infuse/withdraw system

KD Scientific

LEGATO 130

Micromotor Strong 90

Saeshin Precision

Strong90

Drill bits

Hager & Meisinger GmbH

B61984

Cryostat

Thermo

CryoStar NX50 OP

Olympus virtual digital slide slice scanning system

Olympus

VS120

Olympus FV-1200 laser scanning confocal microscope

Olympus

FV-1200

Vibrating blade microtome

Leica

VT1200S

Freezing point osmometer

Löser

OM-806

Digidata 1440A digitizer

Molecular Devices

Digidata 1440A

MultiClamp 700A amplifier

Molecular Devices

Multiclamp 700A

Fixed-stage upright microscope

Olympus

BX51WI

Automatic temperature controller

Warner

TC-324C

X-Cite 110LED Illumination System

Excelitas Technologies

110LED

Sutter MPC-200 micromanipulator

Sutter Instrument

MPC-200

Horizontal pipette puller

Sutter Instrument

P97

Peristaltic pump

Longer Pump

YZ1515x

Antivibration table

TMC

63-561

High Performance CCD Camera

COHU

4912-5010

Black and white monitor

Sunspot

SP-712

Precision balances

Sartorius, Göttingen, Germany

BSA822-CW

pH meter

Mettler Toledo

FE28

 Software

 pCLAMP 10.7 software

Molecular Devices

http://www.moleculardevices.com/products/software/pclamp.html; RRID: SCR_011323

 Mini Analysis Program

Synaptosoft

http://www.synaptosoft.com/MiniAnalysis/; RRID:SCR_002184

 ImageJ

National Institutes of Health

https://imagej.nih.gov/ij/index.html; RRID:SCR_003070

 OlyVIA

Olympus

https://www.olympus-lifescience.com/en/support/downloads/#!dlOpen=%23detail847249644; RRID:SCR_016167

 FV10-ASW software

Olympus

http://www.photonics.com/Product.aspx?PRID=47380; RRID:SCR_014215

The biosafety level of laboratory when applying tracing virus is ABSL-2 (P2) qualified.